DeepLuAd: Semantic-guided virtual histopathology of lung adenocarcinoma via stimulated Raman scattering.
Accurate histologic grading of lung adenocarcinoma is essential for guiding clinical management.
APA
Ma L, Guo Y, et al. (2026). DeepLuAd: Semantic-guided virtual histopathology of lung adenocarcinoma via stimulated Raman scattering.. Theranostics, 16(5), 2324-2341. https://doi.org/10.7150/thno.125443
MLA
Ma L, et al.. "DeepLuAd: Semantic-guided virtual histopathology of lung adenocarcinoma via stimulated Raman scattering.." Theranostics, vol. 16, no. 5, 2026, pp. 2324-2341.
PMID
41424851
Abstract
Accurate histologic grading of lung adenocarcinoma is essential for guiding clinical management. Conventional hematoxylin and eosin (H&E) staining provides morphological information but lacks biochemical specificity, limiting quantitative analysis of tissue subtypes within the heterogeneous lung cancer microenvironments. We developed DeepLuAd, an AI-powered platform integrating label-free stimulated Raman scattering (SRS) microscopy with semantic-guided deep learning. The platform enables automated tumor grading, segmentation, cellular-level morpho-chemical quantification, and unsupervised virtual H&E staining. DeepLuAd achieved a mean intersection-over-union (mIoU) of 80.43% across major lung tissue subtypes and reached a grading concordance rate of 76.2% with pathologist diagnoses (16/21 cases). The approach also enabled quantitative mapping of lipid-to-protein ratio heterogeneity within tumor and stromal compartments, revealing biochemical signatures of disease progression. DeepLuAd provides an interpretable and scalable framework for digital lung adenocarcinoma analysis, unifying morphological and biochemical information without the need for staining. The method demonstrates potential for broader application to other solid tumors in AI-enhanced histopathology.
MeSH Terms
Humans; Adenocarcinoma of Lung; Lung Neoplasms; Spectrum Analysis, Raman; Deep Learning
같은 제1저자의 인용 많은 논문 (5)
- PML::RARA-negative APL-mimicking AML with a novel KMT2C::CREB3L2 fusion and RARA/RXRA-mediated sensitivity to all-trans retinoic acid.
- Association analysis of the differences in intestinal flora and clinical tumor indicators among colorectal cancer patients.
- Differences in Responses to Neoadjuvant Anti-HER2 Therapy between HER2 2+/ISH+ and HER2 3+ in HER2-Positive Breast Cancer.
- Pattern classification based on a multi-spike learning algorithm in a photonic spiking neural network with VCSEL-SA.
- XBP1-driven proliferative B cell subcluster in Diffuse Large B Cell Lymphoma linked to altered nucleotide metabolism.